MGRC | MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD

9 9
0.200 (0.0%)
T-O (am): 0.000 (08:59:00)
Price updated as of: 11:43
Fundamental
Technical
Total Score
MGRC | MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD

MGRC Fundamental Trend

FCON: | Sharpe Ratio: | LTS:


Chart:

MGRC Quarter Reports

Select columns required and click "Update" to save your preferences

Ann. Date Qtr. Date Q FYE Revenue [M] PBT [M] NP [M] NPM DPS EPS R. QoQ R. YoY E. QoQ E. YoY TTM
EPS		 Adj.
[M]		 NP [M]
(adj)		 NPM
(adj)		 EPS
(adj)		 E. QoQ
(adj)		 E. YoY
(adj)		 TTM EPS
(adj)
24 Nov 25 Q3 Sep 2025 3 31 Dec 2025 2.48 0.31 0.39 15.7% 0.00 0.28 38.3% 77.3% 205.1% 141.9%
27 Aug 25 Q2 Jun 2025 2 31 Dec 2025 1.80 -0.45 -0.37 -20.6% 0.00 -0.27 33.1% 37.8% 50.5% 72.2%
26 May 25 Q1 Mar 2025 1 31 Dec 2025 1.35 -0.83 -0.75 -55.5% 0.00 -0.55 3.1% 24.0% 51.4% 46.9%
27 Feb 25 Q4 Dec 2024 4 31 Dec 2024 1.31 -0.57 -0.49 -37.7% 0.00 -0.36 6.6% 41.5% 46.8% 91.9%
27 Nov 24 Q3 Sep 2024 3 31 Dec 2024 1.40 -1.01 -0.93 -66.2% 0.00 -0.68 7.5% 38.1% 30.4% 35.9%
28 Aug 24 Q2 Jun 2024 2 31 Dec 2024 1.30 -1.41 -1.33 -102.3% 0.00 -0.97 26.6% 41.5% 5.3% 87.9%
23 May 24 Q1 Mar 2024 1 31 Dec 2024 1.77 -1.50 -1.41 -79.4% 0.00 -1.03 20.7% 160.9% 76.8% 50.8%
28 Feb 24 31 Dec 2023 Other 31 Dec 2023 2.24 -7.46 -6.07 -271.3% 0.00 -4.42 1.3% 36.1% 319.0% 392.1%
28 Nov 23 30 Sep 2023 Other 31 Dec 2023 2.27 -1.49 -1.45 -63.9% 0.00 -1.07 1.6% 40.6% 86.9% 271.0%
28 Aug 23 Q4 Jun 2023 4 30 Jun 2023 2.23 -9.98 -11.03 -494.9% 0.00 -8.47 227.8% 64.8% 285.4% 376.1%
23 May 23 Q3 Mar 2023 3 30 Jun 2023 0.68 -3.18 -2.86 -420.9% 0.00 -2.20 58.6% 86.6% 132.1% 245.7%
24 Feb 23 Q2 Dec 2022 2 30 Jun 2023 1.64 -1.27 -1.23 -75.0% 0.00 -0.98 56.9% 78.5% 245.6% 222.0%
23 Nov 22 Q1 Sep 2022 1 30 Jun 2023 3.81 0.85 0.85 22.2% 0.00 0.68 39.8% 59.1% 78.8% 254.4%
30 Aug 22 Q4 Jun 2022 4 30 Jun 2022 6.33 2.97 4.00 63.1% 0.00 3.25 24.6% 9278.3% 103.5% 289.7%
23 May 22 Q3 Mar 2022 3 30 Jun 2022 5.08 1.96 1.96 38.6% 0.00 1.60 33.4% 212.2% 94.3% 882.0%
16 Feb 22 Q2 Dec 2021 2 30 Jun 2022 7.63 1.01 1.01 13.2% 0.00 0.83 18.1% 5508.8% 323.0% 165.1%
30 Nov 21 Q1 Sep 2021 1 30 Jun 2022 9.32 0.24 0.24 2.6% 0.00 0.20 13601.5% 10608.0% 111.3% 128.7%
23 Sep 21 Q4 Jun 2021 4 30 Jun 2021 -0.07 -2.11 -2.11 3052.2% 0.00 -1.94 104.2% 2400.0% 1153.0% 61.3%
27 May 21 Q3 Mar 2021 3 30 Jun 2021 1.63 0.20 0.20 12.3% 0.00 0.19 1097.1% 428.6% 112.9% 112.0%
18 Feb 21 Q2 Dec 2020 2 30 Jun 2021 0.14 -1.55 -1.55 -1142.7% 0.00 -1.50 56.3% 97.3% 86.5% 106.4%
30 Nov 20 Q1 Sep 2020 1 30 Jun 2021 0.09 -0.83 -0.83 -957.5% 0.00 -0.80 2800.0% 98.9% 84.7% 2424.2%
21 Aug 20 Q4 Jun 2020 4 30 Jun 2020 0.00 -2.61 -5.44 -181200.0% 0.00 -5.25 99.0% 100.0% 226.9% 304.8%
22 May 20 Q3 Mar 2020 3 30 Jun 2020 0.31 -1.66 -1.66 -539.9% 0.00 -1.61 93.8% 95.3% 106.9% 73.6%
18 Feb 20 Q2 Dec 2019 2 30 Jun 2020 4.96 24.71 24.23 488.6% 0.00 23.41 36.8% 28.4% 73530.3% 2545.2%
19 Nov 19 Q1 Sep 2019 1 30 Jun 2020 7.85 0.10 -0.03 -0.4% 0.00 -0.03 11.8% 24.4% 97.5% 97.7%
27 Aug 19 Q4 Jun 2019 4 30 Jun 2019 7.02 -1.30 -1.34 -19.1% 0.00 -1.30 6.2% 7.0% 40.2% 7.8%
24 May 19 Q3 Mar 2019 3 30 Jun 2019 6.61 -0.93 -0.96 -14.5% 0.00 -0.93 4.6% 4.3% 3.3% 18.6%
22 Feb 19 Q2 Dec 2018 2 30 Jun 2019 6.93 -0.91 -0.99 -14.3% 0.00 -0.96 9.9% 8.5% 31.9% 20.4%
24 Aug 18 Q4 Jun 2018 4 30 Jun 2018 6.31 -1.54 -1.46 -23.1% 0.00 -1.40 3.8% 116.6% 0.1% 534.3%
24 May 18 Q3 Mar 2018 3 30 Jun 2018 6.56 -1.35 -1.46 -22.2% 0.00 -1.41 5.0% 303.1% 80.3% 1301.0%
26 Feb 18 Q2 Dec 2017 2 30 Jun 2018 6.91 -0.69 -0.81 -11.7% 0.00 -0.78 8.2% 237.6% 1.8% 71.5%
22 Nov 17 Q1 Sep 2017 1 30 Jun 2018 6.38 -0.79 -0.82 -12.9% 0.00 -0.80 119.2% 94.2% 345.7% 199.3%
30 Aug 17 Q4 Jun 2017 4 30 Jun 2017 2.91 0.39 0.34 11.5% 0.00 0.32 79.0% 57.3% 422.1% 193.9%
11 May 17 Q3 Mar 2017 3 30 Jun 2017 1.63 -0.09 -0.10 -6.4% 0.00 -0.10 20.5% 9.0% 77.9% 145.6%
21 Feb 17 Q2 Dec 2016 2 30 Jun 2017 2.05 -0.46 -0.47 -23.0% 0.00 -0.46 37.8% 35.9% 156.8% 196.3%
21 Nov 16 Q1 Sep 2016 1 30 Jun 2017 3.29 0.83 0.83 25.2% 0.00 0.88 77.6% 8.7% 627.2% 8.5%
30 Aug 16 Q4 Jun 2016 4 30 Jun 2016 1.85 0.12 0.11 6.2% 0.00 0.12 3.5% 44.8% 50.0% 76.1%
25 May 16 Q3 Mar 2016 3 30 Jun 2016 1.79 0.23 0.23 12.8% 0.00 0.24 44.0% 58.4% 53.4% 82.4%
24 Feb 16 Q2 Dec 2015 2 30 Jun 2016 3.19 0.49 0.49 15.3% 0.00 0.52 11.2% 13.5% 46.0% 63.9%
23 Nov 15 Q1 Sep 2015 1 30 Jun 2016 3.60 0.91 0.91 25.2% 0.00 0.96 7.3% 40.8% 89.9% 82.3%
24 Aug 15 Q4 Jun 2015 4 30 Jun 2015 3.35 0.48 0.48 14.2% 0.00 0.51 21.9% 67.8% 63.2% 103.8%
25 May 15 Q3 Mar 2015 3 30 Jun 2015 4.29 1.30 1.30 30.2% 0.00 1.38 16.2% 914.9% 4.2% 166.1%
13 Feb 15 31/12/14 2 30/06/15 3.69 1.35 1.35 36.6% 0.00 1.44 44.4% 167.0% 172.2% 261.3%

MGRC Historical Dividends

MGRC Financial Ratios

EPS -0.89 sen
Trailing PE (Sector Median: 23.1) 0.0
PEG 0.0
Altman Z -2.2
Beaver 0.145
Current Ratio 3.56
Debt-Equity (DE) Ratio 0.23
FCF Yield 1.99 %
Revenue QoQ 38.31 %
Revenue YoY 77.3%
Profit QoQ 205.14 %
Profit YoY 141.92 %
Profit Margin (Sector Median: 4.8) -17.63 %
ROE (ROIC: -7.02) -7.02 %
Dividend Per Share (DPS) 0.0 sen
Dividend Yield (DY) 0.0 %

MGRC Adjusted Financial Ratios

Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports

EPS
Trailing PE (Sector Median: 23.1)
Profit QoQ
Profit YoY
Profit Margin (Sector Median: 4.8)
ROE (ROIC: -7.02)
Altman Z

MGRC Fair Value

Weighted Average Fair Value:

Discounted Cash Flow (DCF) 5% Growth
Discounted Cash Flow (DCF) 10% Growth
Relative Valuation
Graham Formula
Graham Number
Net Tangible Asset (NTA) 0.13
Consistent QR FV
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit (adjusted) [M] 0.39
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 0.0
Expected Revenue (M) 0.0
Expected Growth (%) 0.0
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research

MGRC Directors Share Purchases (Beta)


ENCIK NOOR AZRI BIN DATO' SRI NOOR AZERAI added 2370000.0 units announced on 08 Aug 2022 at ~RM0.73

ENCIK NOOR AZRI BIN DATO' SRI NOOR AZERAI added 100000.0 units announced on 13 Jul 2022 at ~RM0.955

ENCIK NOOR AZRI BIN DATO' SRI NOOR AZERAI added 100000.0 units announced on 12 Jul 2022 at ~RM0.945

ENCIK NOOR AZRI BIN DATO' SRI NOOR AZERAI added 120000.0 units announced on 08 Jun 2022 at ~RM0.63

DATUK MUNIRAH BINTI HAJI ABDUL HAMID reduced 694000.0 units announced on 16 Jul 2021 at ~RM1.56

DATUK MUNIRAH BINTI HAJI ABDUL HAMID reduced 851679.0 units announced on 24 Feb 2021 at ~RM1.19

TAN SRI DATUK DR RAFIAH BINTI SALIM added 10000.0 units announced on 10 Feb 2021 at ~RM0.88

DATUK MUNIRAH BINTI HAJI ABDUL HAMID reduced 354070.0 units announced on 07 Jan 2021 at ~RM1.05

TAN SRI DATUK DR RAFIAH BINTI SALIM added 20000.0 units announced on 24 Dec 2020 at ~RM0.885

TAN SRI DATUK DR RAFIAH BINTI SALIM added 10000.0 units announced on 22 Dec 2020 at ~RM0.83

TAN SRI DATUK DR RAFIAH BINTI SALIM added 60000.0 units announced on 16 Dec 2020 at ~RM0.78

MGRC Summary


Market Cap: 27 M.

Market Cap Class: Shrimp

Number of Shares: 137 M.

Adjusted Float: 87.3%.

Stock highly correlated with

CJCEN (95%)

PCHEM (95%)

AMTEL (94%)

BAT (94%)

MGRC provides genome sequencing and analysis services. Our services and pipelines are designed to rapidly sequence and analyse large volumes of genetic data and extract meaningful biological information for downstream research and development. The key components of our commercial operations are our Contract Genomics Services, Sequencing Services, and Data and Access Services. Our services and applications have been used extensively in significant projects, including the mapping of the lung cancer genome, and the sequencing and assembly of the oil palm genome. To date, the company have undertaken projects for large agriculture-based companies, major medical research institutions, and government linked or funded entities in Malaysia and abroad, including United States and Australia. Currently, MGRC are the only player in Malaysia providing commercial bioinformatics analysis services for data from multiple second and third generation sequencing machines, serving public and private sector organizations in Malaysia and internationally. They have established themselves as Malaysia's leading provider of Contract Genomics Services

Sectors: Healthcare, Health Care Equipment & Services, Penny Stocks

Share Registrar: ALDPRO CORPORATE SERVICES SDN BHD

Code: 0155

Website: http://www.mgrc.com.my/

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

No warrants listed

MGRC Top Shareholdings

Updated on 30-Sep-2022

Shareholder % Value (M)
Proven Venture Capital Plt 16.32% 4.48
Pixelvest Sdn Bhd 7.54% 2.07
Leong Yien Hung 6.15% 1.69
Bintai Trading Sdn Bhd 5.19% 1.42
Dynamic Prestige Consultancy Sdn Bhd 4.43% 1.22
Magnalogic Sdn Bhd 4.35% 1.19
Lim Wai Yee 3.38% 0.93
Rinani Group Berhad 2.07% 0.57
Munirah binti Haji Abdul Hamid 1.77% 0.49
Keh Chuan Choon 1.62% 0.44
Ong Tzu Chuen 1.57% 0.43
Mohd Rafael bin Mohd Shamsudin 1.56% 0.43
Yeo Tsu Sin 1.47% 0.4
Raja Abdullah Bin Raja Baharudin 1.39% 0.38
Tan Kok Aun 1.23% 0.34
Shia Xze Chyien 1.09% 0.3
Chng Teong Seng 1.08% 0.3
Shia Chee Fong 0.98% 0.27
Inertia AIF Sdn Bhd 0.95% 0.26
Noraziah binti Adnan 0.95% 0.26
Foo Chai Lee 0.92% 0.25
Khoo Hai Chew 0.82% 0.23
Shahril bin Shamsuddin 0.81% 0.22
Lee Chooi Bit 0.78% 0.21
Nor Azah binti Adnan 0.7% 0.19
Ng Soon Leong 0.7% 0.19
Cheong Kai Meng 0.66% 0.18
Keh Chuan Seng 0.64% 0.18
Lee Boon Sze 0.64% 0.18
Encik Muhammad Badri Bin Hussin 0.0% 0.0
Frequently Asked Questions
MGRC provides genome sequencing and analysis services. Our services and pipelines are designed to rapidly sequence and analyse large volumes of genetic data and extract meaningful biological information for downstream research and development. The key components of our commercial operations are our Contract Genomics Services, Sequencing Services, and Data and Access Services. Our services and applications have been used extensively in significant projects, including the mapping of the lung cancer genome, and the sequencing and assembly of the oil palm genome. To date, the company have undertaken projects for large agriculture-based companies, major medical research institutions, and government linked or funded entities in Malaysia and abroad, including United States and Australia. Currently, MGRC are the only player in Malaysia providing commercial bioinformatics analysis services for data from multiple second and third generation sequencing machines, serving public and private sector organizations in Malaysia and internationally. They have established themselves as Malaysia's leading provider of Contract Genomics Services The company is listed on Bursa Malaysia and operates in the Healthcare, Health Care Equipment & Services and Penny Stocks sectors.
Yes, MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD is listed as Shariah-compliant.
The latest share price of MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD is RM 0.200 updated on 28 January 2026 11:43.
As of now, MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD has a market capitalization of 27M based on the latest financial data.
iSaham's technical analysis indicates that MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD's support level is at RM 0.2 and its resistance level is at RM 0.2, based on moving averages and price patterns.
The 52-week high for MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD is RM 0.24
MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD's share price has decreased by -41.18% year-to-date, influenced by market trends and company performance.
Dividend information for MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD has not been reported yet. Track MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD's upcoming dividend announcements, yield changes, and payout history easily with the iSaham Stock Screener.
The main shareholders of MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD include Proven Venture Capital Plt, Pixelvest Sdn Bhd and Leong Yien Hung. View more on MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD Top Shareholders page.
You can buy MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD shares through any licensed online broker or trading platform registered with Bursa Malaysia. If you're new to investing, iSaham can help you open an account with M+ Online, one of Malaysia's leading brokers.
When you open your M+ account through the iSaham team, you can get iSaham Pro for free as a bonus offer.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.